4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-22-000057
CIK 0001133416other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 3:59 PM ET
Size
5.9 KB
Accession
0001133416-22-000057
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2022-04-18$1.71/sh+5,000$8,550→ 60,000 total(indirect: By LLC)
Holdings
- 16,000(indirect: By IRA)
Common Stock
- 23,469
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 3:59 PM ET
- Size
- 5.9 KB